MYC Amplification for Angiosarcoma | NeoGenomics Laboratories

Code

FSH-MYCA-01AX

Test

Active-Compendium

88374x1 automated or 88377x1 manual.

Clinical

Pathology

Paraffin Block: Send paraffin block. Also send circled H&E slide for tech-only (required).
Cut Slides: H&E slide (required) plus 4 unstained slides cut at 4-5 microns. Circle H&E slide for tech-only.
Bone Marrow Aspirate: N/A
Peripheral Blood: N/A
Fresh, Unfixed Tissue: N/A
Fluids: N/A

Solid Tumors

Central nervous system (CNS)

GIST/Soft Tissue

Mon, 01/13/2025 - 12:00

Wed, 01/22/2025 - 12:00

FISH

Global

Technical Only

Flag Active

True

Orderable Test Description

Probes: MYC (8q24) | Centromere 8
Disease(s): Angiosarcoma

Orderable Turn Around Time

3-5 Days

Keywords

Meta Description

MYC gene dysregulation is observed in various cancer types. Assessing MYC [c-MYC] amplification status provides diagnostic, prognostic info to distinguish post-radiation angiosarcoma from other angiosarcomas & non-neoplastic vascular proliferations.

Extra Note

Use cold pack for transport, making sure cold pack is not in direct contact with specimen.

Orderable Biomarkers

MYC

NY Approved

False

Orderable Biomarkers JSON

{"Fluorescence In Situ Hybridization (FISH)": {"Amplification(s)": ["MYC"]}}

Keywords string

MYC, c-MYC, Angiosarcoma, sarcoma MYC Amplification for Angiosarcoma

Title URL

myc-amplification-for-angiosarcoma